Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	930.47	151.60	14.71
Graham Fair Price	95.00	2.03	1.04
PEG	-93.07	< 0.005	0.09
Price/Book	1.05	0.17	0.17
Price/Cash Flow	-52.69	-5.72	-3.75
Prices/Earnings	-76.59	-3.09	13.21
Price/Sales	204.38	1.25	0.41
Price/FCF	-52.69	-5.72	-3.75
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-20.04	0.31	0.39
Operating Margin	130.98	-0.10	0.04
ROA	340.69	< 0.005	< 0.005
ROE	< 0.005	-0.01	331.61
ROIC	< 0.005	< 0.005	-504.94
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	-0.05	-26.78
Dividends QOQ	< 0.005	-0.32	-11643.20
EBIT QOQ	3.23	-1.76	-45.67
EPS QOQ	1.47	-4.97	237.84
FCF QOQ	-2.68	0.35	-87.04
Revenue QOQ	0.63	-0.67	6.16
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	876.16	2322.97	165.13
Days Sales Outstanding (DSO)	22.90	74.69	226.16
Inventory Turnover	0.10	0.04	-62.28
Debt/Capitalization	0.64	0.66	1.64
Quick Ratio	0.13	0.07	-42.57
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.88	3.65	-6.14
Cash	0.37	-0.02	-94.96
Capex	< 0.005	-0.02	-103.78
Free Cash Flow	-0.17	-0.11	37.88
Revenue	1.59	0.50	-68.84
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.18	2.26	3.61
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.73	133.61	949.77
Naive Interpretation	Member

06 - Financial Health · Bad

Rating